Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

News2000January › Progestogen linked with blood clots › January 2000

Progestogen linked with blood clots

Synthetic progesterone taken for therapeutic purposes such as dysfunctional uterine bleeding may increase the risk of heart disease, according to new data

Synthetic progesterone taken for therapeutic purposes such as dysfunctional uterine bleeding may increase the risk of heart disease, according to new data.

The new information comes from the snappily titled WHO Collaborative Study of Cardiovascular Disease (CVD) and Steroid Hormone Consumption (SHC). The researchers were working on the basis that the risk of heart disease with injectable progestogen has already been established.

In this multinational hospital based study, researchers looked at women aged 20 to 49 years who reported a first episode of either venous thromboembolism (VE), stroke or serious heart attack during the six year study period.

Each woman in the study group was matched with up to three comparable controls. Results showed that the greatest risk for therapeutic progestogens users was for venous thromboembolism.

The researchers point out that the women in this group were older, tended to be heavy cigarette smokers and also

to have a family history of cardiovascular disease. Nevertheless, even after adjusting for these factors, the results did not alter significantly. Women taking therapeutic progestogen still had nearly six times the risk of VE than non users (Lancet, 1999; 354: 1610). This risk is similar to that which has been reported for combined oral contraceptives, but greater than previously reported figures for progestogen only contraceptives. The risk of progestogen users developing stroke or heart disease was not significantly different than that of non users.

Progestogen preparations used for therapeutic purposes can differ from that used in oral contraceptives in several ways. For instance, there may be different progestogens, or they may be in substantially larger doses.


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved